Trial intelligence / Profile preview

Dabigatran in a Drug Interaction Cocktail in Healthy Volunteers

NCT02361619Phase 1Completed

Sponsor
Turku University Hospital
Start
Feb 2015
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of dabigatran, sponsored by Turku University Hospital. Primary endpoint: Area Under the Curve of dabigatran in plasma at 24 hours. Started Feb 2015; status: completed.

02

Drugs

dabigatran

Beyond the preview

Go deeper on NCT02361619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02361619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call